Bcr-Abl
Bcl-Abl is a constitutively activated chimeric tyrosine kinase which is the genetic abnormality expressed in patient with CML (chronic myeloid leukemia).
- C5826 AG957Summary: 酪氨酸磷酸化抑制剂
- C3677 PD 166326Summary: 受体酪氨酸激酶抑制剂
- B6033 GNF-7Summary: II型Bcr-Abl抑制剂
- B1404 DCC-2036 (Rebastinib)Target: FLT3|Bcr-Abl|Tie-2|KDRSummary: Bcr-Abl抑制剂
- B1011 Bafetinib (INNO-406)2 Citation中文名: 巴氟替尼Summary: Bcr-Abl/Lyn酪氨酸激酶抑制剂
- B1402 GZD824Target: Bcr-AblSummary: Bcr-Abl抑制剂
- A8812 PD173955Target: Bcr-Abl|SrcSummary: Src/Abl激酶双重抑制剂
- A8607 PPY ATarget: Abl kinasesSummary: Abl激酶抑制剂
- A8606 PD 180970Summary: P210 bcr/abl酪氨酸激酶抑制剂
- A8605 1-Naphthyl PP1Summary: Src家族激酶抑制剂